Key Drivers
- Profitability Rebound
- Negative Free Cash
- High Leverage
AIAI Summary
ARX is now a merger-arbitrage trade, not a standalone growth investment: buying near $19.66 offers only ~3% upside to Thoma Bravo's $20.25 cash bid versus potentially severe downside toward the pre-deal $12–14 range if litigation, governance, or closing risks derail the deal.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Profitability Rebound
- •Negative Free Cash
- •High Leverage
ARX's quarterly profitability rebound is encouraging, but negative cash flow, heavy liabilities, and a high valuation warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Support Holding
- •Resistance Capping
- •Range Consolidation
ARX consolidated over the last month, with a hold above $19.55–$19.57 favoring stability while a breakout above $19.84–$19.88 would signal renewed upside.
Sharp
Sentiment & News
Key News Insights:
- •Take-Private Bid
- •Golden Cross
- •Fairness Scrutiny
ARX surged on Thoma Bravo's $20.25 take-private bid, but shareholder investigations and fairness concerns present deal-risk.
The proposed acquisition supports ARX near the offer price, while legal scrutiny could create closing-risk volatility
Similar Companies in Financial Services
Other companies in the same sector with AI ratings